UiPath Inc (NYSE: PATH) opened in the red this morning after the firm’s muted full-year outlook tempered its Q4 beat and announcement of a new $500 million share repurchase programme. To some, the ...

UiPath is expanding its partnership with Deloitte through the professional services company's new Agentic ERP offering.

On March 12, 2026, investors weighed UiPath’s first full-year profit against slowing growth and divided Wall Street views.

PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath’s PATH advantage in the current automation race lies in how effectively its platform converts AI innovation into consistent enterprise efficiency. The company is moving beyond traditional ...

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

MINNEAPOLIS--(BUSINESS WIRE)--Deluxe, a trusted Payments and Data company, today announced it has been named an UiPath AI25 Award Winner. The annual award program identifies the 25 most innovative ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

UiPath is a leading robotic process automation company that aims to automate routine tasks, allowing humans to focus on more complex and creative work. Cathie Wood and Ark research believe "Automation ...